| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P2093 | author name string | Farukh A Durrani | |
| Shousong Cao | |||
| Youcef M Rustum | |||
| Rami G Azrak | |||
| Cheryl Frank | |||
| Zhan-Rong Li | |||
| Ming-Biao Yin | |||
| P2860 | cites work | Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage | Q57188003 |
| Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways | Q71842156 | ||
| Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention | Q72785994 | ||
| The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer | Q95721798 | ||
| The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis | Q24291114 | ||
| Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is selectively eliminated from the nucleus at the onset of S phase | Q24310880 | ||
| PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2 | Q24313485 | ||
| Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. | Q24523723 | ||
| Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350 | Q28371796 | ||
| PML is essential for multiple apoptotic pathways | Q28508348 | ||
| Rapid destruction of human Cdc25A in response to DNA damage | Q28611930 | ||
| New colorimetric cytotoxicity assay for anticancer-drug screening | Q29615418 | ||
| Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase | Q33723955 | ||
| Targeted destruction of DNA replication protein Cdc6 by cell death pathways in mammals and yeast | Q33787836 | ||
| Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. | Q34059976 | ||
| Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner | Q34324643 | ||
| Major DNA fragmentation is a late event in apoptosis | Q34431596 | ||
| Origin licensing and programmed cell death: a hypothesis. | Q34786469 | ||
| Apoptosis induced by topoisomerase inhibitors | Q35137789 | ||
| Chk1 signaling pathways that mediated G(2)M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350. | Q38363888 | ||
| Current ideas on selenium as a chemopreventive agent | Q39542893 | ||
| Human replication protein Cdc6 is selectively cleaved by caspase 3 during apoptosis | Q40714032 | ||
| Antisense inhibition of Chk2/hCds1 expression attenuates DNA damage-induced S and G2 checkpoints and enhances apoptotic activity in HEK-293 cells | Q40780586 | ||
| Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis | Q40980452 | ||
| Characterization of tumor-associated Chk2 mutations | Q42495187 | ||
| Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 | ||
| On the nature of selenium toxicity and carcinostatic activity | Q43981962 | ||
| Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis | Q44509795 | ||
| Drosophila Chk2 is required for DNA damage-mediated cell cycle arrest and apoptosis | Q47072850 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 153-160 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression | |
| P478 | volume | 66 |
| Q45221641 | Activation of budding yeast replication origins and suppression of lethal DNA damage effects on origin function by ectopic expression of the co-chaperone protein Mge1. |
| Q53617220 | Apoptosis in budding yeast caused by defects in initiation of DNA replication. |
| Q46658012 | Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? |
| Q40050548 | Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species |
| Q46618372 | Interaction of diazinon with DNA and the protective role of selenium in DNA damage |
| Q46733332 | Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. |
| Q37852056 | Kinase regulation by sulfur and selenium containing compounds. |
| Q46978068 | Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells |
| Q40079860 | Potential involvement of serine/threonine protein phosphatases in apoptosis of HepG2 cells during selenite treatment. |
| Q82735480 | Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced |
| Q46765576 | Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity |
Search more.